Cady, Roger, M.D.
Quick facts
Marketed products
- Dextromethorphan and quinidine
- naratriptan HCl · Neurology
Naratriptan selectively binds to serotonin 5-HT1B/1D receptors on cranial blood vessels and nerve terminals to constrict blood vessels and inhibit neuropeptide release, thereby relieving migraine headaches.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: